Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Zhongshan Hoapital, Shanghai